News

Filter

Current filters:

None

64 to 73 of 96601 results

Oriola-KD considering selling Russian business

21-10-2014

Finland’s Oriola-KD, a leading pharmaceutical retail and wholesale companies operating in Northern…

Mergers & AcquisitionsOriola-KDPharmaceuticalRussia

Chinese heparin API market to account for about 80% of global demand; report

Chinese heparin API market to account for about 80% of global demand; report

21-10-2014

It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional…

Cardio-vascularChinaGenericsMarkets & Marketing

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

21-10-2014

Specialty biopharma company Auxilium Pharmaceuticals has received approval from the US Food And Drug…

Anti-Arthritics/RheumaticsAuxilium PharmaceuticalsBiotechnologyRegulationUSAXiaflex

Eurofins Genomics extends genomic business into Austria and Czech Republic

Eurofins Genomics extends genomic business into Austria and Czech Republic

21-10-2014

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, and international market leader…

AustriaBiotechnologyEurofins GenomicsGeneticsMarkets & Marketing

Ashland Specialty Ingredients opens new pharma center in Wilmington, Delaware

Ashland Specialty Ingredients opens new pharma center in Wilmington, Delaware

21-10-2014

Ashland Specialty Ingredients, the commercial unit of Ashland Inc, has opened a new pharma center in…

AshlandAshland IncPharmaceuticalProductionUSA

FDA panel unanimously backs Novartis’ secukinumab for moderate-to-severe plaque psoriasis

FDA panel unanimously backs Novartis’ secukinumab for moderate-to-severe plaque psoriasis

21-10-2014

The Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the US Food and Drug Administration…

DermatologicalsNovartisPharmaceuticalRegulationsecukinumabUSA

FDA fast-tracks Taiho Oncology’s TAS-102 for colorectal cancer

FDA fast-tracks Taiho Oncology’s TAS-102 for colorectal cancer

20-10-2014

The US Food and Drug Administration has granted Fast Track designation for TAS-102 (trifluridine and…

OncologyOtsukaPharmaceuticalRegulationTaiho OncologyTAS-102USA

FDA accepts Eisai's supplemental New Drug Application for Fycompa in tonic-clonic seizures

FDA accepts Eisai's supplemental New Drug Application for Fycompa in tonic-clonic seizures

20-10-2014

Japanese drug major Eisai has had a supplemental New Drug Application for its in-house-discovered AMPA…

CNS DiseasesEisaiFycompaJapanPharmaceuticalRegulation

64 to 73 of 96601 results

Back to top